Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China
· Delayed Price · Currency is CNY 42.99
-0.93 (-2.12%)
Jun 6, 2025, 3:04 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Anesthesia | 849.67M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anesthesia Growth | 94.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Parenteral Nutrition | 615.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Parenteral Nutrition Growth | -4.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Raw Materials | 569.78M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services | 413.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tumor Antiemetic | 211.72M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tumor Antiemetic Growth | -20.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibiotics | 118.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibiotics Growth | 21.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular and Cerebrovascular | 67.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular and Cerebrovascular Growth | -24.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hepatobiliary Digestion | 67.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hepatobiliary Digestion Growth | 1.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | 19.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Growth | 17.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 421.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 13.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APIs and Patented Technology | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APIs and Patented Technology Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Marketing | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Marketing Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 3.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 11.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|